Perceptive Inc. · 2 months ago
Scientist I - Image Analysis/Dosimetry - Oncology
United States
Full-time
Remote
Entry, Mid Level
$64K/yr - $120K/yr
2+ years expPerceptive Inc. is dedicated to shaping the future of clinical research, helping the biopharmaceutical industry bring advanced medical treatments to market. They are seeking an Image Analysis Scientist to manage and perform analysis work on medical imaging-based clinical trials, focusing on quantitative decision-making data in radioligand therapy dosimetry studies.
Clinical TrialsHealth CarePharmaceutical
Responsibilities
Analyze nuclear medical imaging data, gamma counter data and associated non-image data
Manage data (including in DICOM format) on online project repositories
Oversee processing of imaging data, including registration, segmentation, ROI quantification
Interact with sponsors around study setup and results interpretation
Draft project documentation and regulatory documents
Ensure quality control of analysis projects
Analysis project management
Create images, plots, and reports for clients
Effectively utilize in-house developed python workflows, iPACS, MIM
Automate workflows by implementing software scripts
Guided internal development work
Qualification
Required
PhD or MSc in a relevant field (e.g. engineering, mathematics, physics, chemistry or biology)
Minimum of 2 years relevant experience in medical image analysis
Required experience analyzing imaging data from nuclear medicine imaging modalities (e.g. PET, SPECT)
Preferred
Candidates located in the following states are preferred: AZ, CT, DE, FL, GA, IL, MA, MO, NH, NJ, NC, PA, UT, VA
Benefits
Medical, Dental and Vision benefits for you and your family, including Flexible Spending Accounts (FSA) and Health Savings Accounts (HSAs)
Paid time off policy including holidays and sick time
Internal growth and development programs & trainings
401(k) program, life & accident insurance and disability insurance
Company
Perceptive Inc.
Expanding on their combined 50-year history, Perceptive provides best-in-class specialist support to global pharmaceutical, biotech, and clinical research organizations, spanning the complete R&D lifecycle, from discovery and preclinical through clinical development to post marketing.
1001-5000 employees
Funding
Current Stage
Late StageTotal Funding
$15MKey Investors
CapVest
2026-01-08Private Equity· $15M
Recent News
2026-01-23
2025-12-11
Company data provided by crunchbase